Clinical Significance of Thrombospondin Type 1 Domain-Containing 7A and Neural Epidermal Growth Factor-Like 1 Protein in M-Type Phospholipase A2 Receptor-Negative Membranous Nephropathy.
10.3881/j.issn.1000-503X.15212
- Author:
Xuan-Li TANG
1
;
Yuan-Yuan DU
1
;
Jin YU
1
;
Tian YE
1
;
Hong ZHU
1
;
Yin-Feng CHEN
1
;
Xiao-Hong LI
1
Author Information
1. Key Laboratory of Kidney Disease Prevention and Control Technology,Department of Nephrology,Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University,Hangzhou 310007,China.
- Publication Type:Journal Article
- Keywords:
M-type phospholipase A2 receptor;
membranous nephropathy;
neural epidermal growth factor-like 1 protein;
thrombospondin type 1 domain-containing 7A
- MeSH:
Humans;
Autoantibodies;
Clinical Relevance;
Colonic Neoplasms;
EGF Family of Proteins;
Glomerulonephritis, Membranous/diagnosis*;
Nephrotic Syndrome;
Receptors, Phospholipase A2/metabolism*;
Thrombospondins/metabolism*
- From:
Acta Academiae Medicinae Sinicae
2023;45(2):235-244
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical significance of thrombospondin type 1 domain-containing 7A (THSD7A) and neural epidermal growth factor-like 1 protein (NELL1) in phospholipase A2 receptor (PLA2R)-negative membranous nephropathy (MN). Methods A total of 116 PLA2R-negative MN patients treated in Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University from 2014 to 2021 were enrolled in this study.Immunohistochemistry was employed to detect THSD7A and NELL1 in the renal tissue.The pathological characteristics,treatment,and prognosis were compared between positive and negative groups. Results The 116 PLA2R-negative MN patients included 23 THSD7A-positive patients and 9 NELL1-positive patients.One patient was tested positive for both proteins.The THSD7A-positive group showed higher positive rate of IgG4 (P=0.010),more obvious glomerular basement membrane (GBM) thickening (P=0.034),and higher proportion of stage Ⅱ MN and lower proportion of stage I MN (P=0.002) than the THSD7A-negative group.The NELL1-positive group had lower positive rates of C1q and IgG2 (P=0.029,P=0.001),less obvious GBM thickening (P<0.001),more extensive inflammatory cell infiltration (P=0.033),lower proportion of deposits on multi-locations (P=0.001),and lower proportion of atypical MN (P=0.010) than the NELL1-negative group.One patient with THSD7A-positive MN was diagnosed with colon cancer,while none of the NELL1-positive patients had malignancy.Survival analysis suggested that THSD7A-positive MN had worse composite remission (either complete remission or partial remission) of nephrotic syndrome than the negative group (P=0.016),whereas NELL1-positive MN exhibited better composite remission of nephrotic syndrome than the negative group (P=0.015).The MN patients only positive for NELL1 showed better composite remission of nephrotic syndrome than the MN patients only positive for THSD7A (P<0.001). Conclusions THSD7A- and NELL1-positive MN is more likely to be primary MN,and there is no significant malignancy indication.However,it might have a predictive value for the prognosis of MN.
